Loading clinical trials...
Loading clinical trials...
Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections of Superficial Malignant Esophageal Neoplasms: a Randomized Clinical Trial.
Conditions
Interventions
Submucous Endoscopic Dissection with hydroxyethylamide
Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)
Locations
1
Brazil
Instituto do Câncer do Estado de São Paulo
São Paulo, São Paulo, Brazil
Start Date
June 19, 2023
Primary Completion Date
December 30, 2024
Completion Date
April 13, 2026
Last Updated
May 1, 2025
NCT05875870
NCT07035587
NCT06070376
NCT04008407
NCT05804331
NCT06379997
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions